Summary: A definitive method is described for the determination of cortisol in human plasma. The method is based on the principle of isotope dilution-mass spectrometry.
Introduction
"Definitive Methods" have been defined äs "Methods which after exhaustive investigation are found to have no known source of inaccuracy or ambiguity" (1) . In the field of hormone determinations, the accuracy of results obtained by the methods currently in use cannot be proven, since none of these methods has been checked by a definitive method. Only when this is achieved will it be possible to determine which methods in routine use produce results with a high degree of accuracy. Without such assurance, laboratories will not be ready to concentrate on selected methods for measuring a specific hormone, and therefore interlaboratory, and international differences will be perpetuated. It is now generally accepted that the technique of isotope dilution-mass spectrometry may serve äs a powerful analytical tool for the highly accurate determination of low molecular substances in biological fluids. In view of the above considerations it seemed reasonable to apply this technique to. the specific and accurate determination of steroid hormones in human plasma. The general prinĉ iples of the analytical procedures involved have already been outlined previously (2, 3) . In the present paper, ä definitive method for the determination of coftisol in human plasma is described in detail.
Principle of the Method
A defmite amount of isotopically labelled· cortisol is equilibrated with the endogenöus non-labelled cortisol in the plasma sample. The steroids are extracted, purified by column chromatography and converted to a derivative suitable for gas liquid chromatography-mass spectrometry. In order to measure the isotope ratio of the nonlabelled to the labelled cortisol, the steroid derivatives are subjected to selected ion monitoring. The mass spectrometer is adjusted to record simultaneously the molecular ion and a fragment ion of the cortisol derivative äs well äs of the corresponding isotopically labelled internal Standard. The amount of endogenöus nonlabelled cortisol in the plasma sample is calculated from the isotope ratio.
Materials and Procedure Reagents
l4-l4 C]Cortisol (spec. activity 2.035 GBq/mmol) was obtained from the Radiochemical Centre, Amersham, UK; the purity of the labelled substance was checked by selected ion recording and the material proved to be satisfactory for the use äs internal Standard. Cortisol was supplied äs certified reference material (Standard reference material 921) from the National Bureau of Standards, Washington, DC, USA. Testosterone 3-enol, 170-dipentafluoropropionic ester was prepared by reacting testo^· sterone (Schering, Berlin-West) with pentafluoropropionic acid anhydride in acetone for 30 min at room temperature. Methoxyamine hydrochloride was purchased from Merck (Darmstadt, FR Germäny), N-methyl-N-trimethylsilyl triflüoroacetie ämide from Macherey & Nagel (Düren, FR Germäny), bromotrimethylsilane from PCR (Gainesville, Florida, USA) and pentafluoropropionic acid anhydride from Pierce (Rotterdam, The Netherlands). Sephadex LH-20 was obtained from Pharmacia '(Freiburg, FR Germany) and Chromosorb W-HP, cqated with 3% Dexsil 300, from WGA (Darmstadt, FR Germany). Dichloromethane used for the extraction of cortisol from the plasma samples was treated with l mol/1 aqueous NaOH solution prior to use. Pyridine had a water content of less than 0.01% and acetöne of less than 0.1% (Merck, Darmstadt, FR Germany) CJcortisol Standard solution, a 100 ^ and a 25 -syringe (SGE, Melbourne, Australia) equipped with repeating adaptors are used respectively. The 100 syringe is calibrated by sampling and weighing 50 water. The loss öf water during the sampling and weighing pfOcedure,.due to evaporation of the sok vent, is cqrrected for by weighing the water säniples 45 arid 90 s after sampling and calculating the original weight at 0 s.
Weighing Procedure
The cortisol certified reference rnaterial (National Bureau of Standards, Washington) and the 50 water samples for calibrating the 100 syringe are weighed with an electronic balance (model 4135, Sartorius, Göttingen, FR Germany). For calibfäting the 0.5 ml, l ml and 2 ml enzyme test pipettes a meehanical balance (model 2432, Sartorius, Göttingen, FR Germany) is used. The accuracy of the balance s is checked with qfficially calibrated weights.
Instruments and Settings
An LKB 9000 combined gas chromatograph-mass spectrometer, equipped with the LKB 2031 Computer System is used. The gas liquid chromatography colurnn (130 X 0.25 cm) is operated by a linear temperature Programme frpm 260 to 290 °C with a temperature rate of 3 °C/mih. Helium is used äs carriergas at a flöw rate of 15 ml/min. The injection temperature of the gas Chromatograph is set to 280 °C and that of the molecular Separator to 290 °C. The ion source of the mass spectrometer is operated at 310 ° C with an energy of the electron beam of 26 eV anä an ionising current of 120 . The high voltage of the electron multiplier is set to 3400 V.
Sample Preparation
To 0.4-1.5 ml plasma is added 25 ' an ethanolic solution, containing approximately 110 ng of [4r^4C]cortisol, iisirig the 25 syringe equipped with the repeating adaptor. In order to obtain 1:1 isotope ratios which are most favourable in definitive measurements, the amount öf plasma to be üs.ed in the experiment is first determined by a preliminary analysis. The plasma sample is equilibrated with the labelled Cortisol by gently shiaking the test tube for 30 min at room temperature. 15 ml of dichloror methane is added and the mixture mechänically shakeri for 30 min at room temperature. The aqueous phase is aspirated; the organic phase is washed twice with l ml water and evapörated to dtyness under nitrogen at 60 °C-
Column Chromatography
The column is prepared by placing 0.8 g of Sephadex LrMp into aglass column (30 X 0.4 cm), equipped with a sintered disc. The column is rinsed with 100 ml of methanpl and then equilibrated with 15 ml of a solvent mixture, consisting of dichlbromethane, cyclphexane, methanol and water (100 + 80 + 15 + 1, by vol). The residue of the purified plasma extract is taken up twiee in 100 of the solvent mixture and transferred to the column. the column is first washed with 7 ml öf the solr vent mixture and the cortisol fraction eluted with further 2 ml of the solvent mixture. Since the elution p ttern is temperaturedependent and may slightly vary from one batch to another, it is recommended that the exact position of the Cortisol fraction be checked by chromatographing a small portion of [4-1< *C]cortisol on a separate column and measuring the radioactivity in 0.5 ml fractions. The cortisol fraction obtained after column chromatography is collected in conical test tubes (total volume 2 ml) and the organic phase evaporated under nitrogen at 60 °C.
Formation of Derivatives
The cortisol-containing residue in the conical tube is reacted with 20 μΐ of a solution of 10 g/l methoxyamine hydrochloride in pyridifie overnight at room temperature. The solvent is evaporated under nitrogen at 60 °C and the residue dried under vacuum in a desiccator. To form the trimethylsilyl ether, 10 μΐ of a mixture of trimethylsilylbromosilane, pyridine and N-methyl-N-trimethylsilyl-trifluoroacetic amide (5 + 5 + 90 , by vol) is added to the residue. The mixture is kept for at least 30 min at room temperature.
Preparation of Standard Solutions
To prepare the l4 C-labelled cortisol Standard solution, the radioactively labelled cortisol (370 KBq), s obtained from the supplier in l ml benzene/ethanol, is transferred to a test tube (2X8 cm); the solvent is evaporated and the [ 14 C]cortisol is dissolved in 12.5 ml ethanol, thus yielding a concentration of about 110 ng/ 25 μΐ (4,4 mg/1). The solution is stored at -20 °C and allowed to equilibrate to 20 °C prior to use. For the preparation of the non-labelled cortisol Standard solution, adefinite amount in the r nge from 29 to 31 mg (e.g. 30.187 mg) of the certified reference cortisol (purity 98.9%, estimated inaccuracy 0.2%) is weighed into a 500 ml Volumetrie flask (off!· cially calibrated, estimated inaccuracy 0.25 ml). The weight is multiplied by the factor 0.989 in order to correct for the impurities s stated in the certificate of the reference material, thus yielding a corrected weight of 29.855 mg. The flask is filled up to the mark with methanol at 20 °C and the contents shaken vigorously for complete dissolution and distribution-The solution is used s concentrated stock solution and stored at -20 ° C. For the preparation of a diluted cortisol solution, l ml of the concentrated stock solution is transferred tp a 100 ml Volumetrie flask (officially calibrated, estimated inaccuracy 0.1 ml) by the use pf an enzyme test pipette (calibrated by pipetting arid weighing 12 sample's of l ml water at 20 °C, volume = 1.0117 ml ± 0.0017 ml). The 100 ml Volumetrie flask is fdled with methanol at 20 ° C to the mark and the content shaken vigorously for distribution. The final diluted cortisol Standard solution contains 30.204 ng/50 μΐ (604,08 μ^/Ι). The solution is stored at -20 °C and equilibrated at 20 °C prior to use.
Preparation of Standards
Three differeht Standards are included in each analytical series: Standard A, prepared in triplicate, consists of a mixture of 25 μΐ pf the ethanolic [4- pipetted with the calibrated 100 μΐ syringe (five times 50 μ l). Standard C contains 150.988 ng cortisol. It should be noted that it is not necessary to know the exact weight of [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C)cortisol in Standards and samples and therefore the chemical and radiochemical purity of the labelled substance is not critical; however it is important that the amount of [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]cortisol in the Standards is exactly the same s that added to the plasma samples; this is achieved by using the same syringe with the repeating adaptor for the two procedures. Moreover, the amount of non-labelled cortisol in the Standard samples must be exactly known. The Standard mixtures are evaporated under nitrogen at 60 °C and the residues are dried und ei vacuum in a desiccator. The methoxime-trimethylsilyl ether derivatives are prepared s described above.
Gas Chromatography-Mass Spectrometry 20 μg of testosterone 3-enol,170-dipentafluoropropionic ester is introduced into the ion source of the mass spectrometer by the use of a direct inlet System. The magnetic field is adj sted to the molecular ion of the testosterone derivative (m/z 580). This molecular ion is used to continuously correct, by means of the Computer System, the temperature-dependent drift of the magnetic field strerigth during the actual recordings of the cortisolspecific m/z-values. The high voltages necessary for the recording of these m/z-values (605, 607, 636 and 638) are calculated by the Computer System and adj sted by means of a digital-analogue Converter. The mixture containing the cortisol derivative is injected into the gas liquid chromatography column. During gas chromatography the Signals obtained at the four cortisol-specific m/e-values are continuously recorded by the Computer and stored on a magnetic disc. The Signal for each of the m/z-values is integrated over a period of 75 ms. For the final inspection of the peak shapes, the selected ion monitoring chromatograms are reconstructed by the Computer and made visible on a display. The quantitative evaluation of peak heights is carried out either manually with a cross hair Cursor or automatically by the Computer Programme. A phot graph of the Computer terminal display after processing a plasma sample is shown in figure 1 . Each Standard and plasma sample is an lysed in two separate selected ion monitoring runs. The mean isotope ratio obtained after the two injections is used for the calculation of the analytical results. It should be noted that the plasma and Standard samples are injected alternately in order to keep the measurement System under continuous control.
Calculation Proceduie
The concentration of cortisol in the plasma sample is calculated from the ratio of the peak heights measured at m/z-values 605 and 607. The recordings at m/z-vaiues 605 and 607 are checked by measuiements at m/z-values 636 and 638; calculation is carried out accordingly. For the calculation of the analytical results it must be taken into account that the radioactively labelled cortisol is not available s isotopically pure material; it contains 19.1% of non-labelled steroid. On the other hand, due to the natural isotope composition of the chemical elements, the non-labelled steroid to be determined contributes to a certain extent to the recording of the 14 C4abelled cortisol derivative. Moreover, there may be a small alternate interference depending on the resolution of the Instrument. On the basis of these considerations the following equation is formulated:
whereby X = amount of cortisol to be calculated, I = intensity of the non-labelled cortisol in the plasma sample, I* = intensity of the labelled cortisol in the plasma sample, f i = ratio I/I* in the labelled cortisol, fa = ratio I*/I in the non-labelled cortisol, fo = proportional factor, S = amount of labelled cortisol present in the plasma sample. It is obvious that the amount of steroid to be calculated is proportional to the ratio I/I* of the non-labelled to the labelled materials äs measured by multiple ion detection and to the amount of labelled Standard material S which is added to the serum samples. The terms -fil* and -f^I are necessary to correct for the alternate contribution of the isotope fractions. The above mentioned formula is simplified to
whereby R =1/1* (intensity ratio of non-labelled to labelled in the plasma sample äs measured by isotope dilution-mass spectrometry)
Due to the alternate isotope contribution of the non-labelled and the labelled cortisoi, the Standard curve is not linear and in addition shows an intercept at the origin. The parameters f j arid f2 of the formula are directly measured äs isotope ratios in the labelled and in the non-labelled cortisoi respectively, The third Parameter of the formula f 0 S is obtained after measuring the isotope ratio R of a Standard mixture and insertion of the knqwn amount of non-labelled cortisoi (X) äs well äs f i and into the formula..
So far the calculation procedure is based on theoretical grounds and therefore produces accurate results äs discussed earlier (3). However, it should be noted that the precision of the measurement of the low isotope ratios f i and i^ for the labelled and the non-labelled Cortisol is significantly lower äs eompared to the precision of the measurement of a Standard mixture which has a ratio of äboüt one. The lower precision of thef j-and fVmeasurements may contribute to a small ambiguity of the positiön of the Standard curve. Although the resulting imprecisipn of the Standard curve would be in the order of 1% only, an improved method for calculating the parameters fi, and foS was developed.
Clearly, more precise results are obtained when the three parameters are calculated from Standard samples with isotope ratios near to unity. For the deterniination of the parameters f , and f öS the measurement of the three Standard mixtures A, B, and C is required. In the present investigation isotope ratios 1 of the non-labelled to the labelled cortisoi in the ränge öf 0.75: l, l: l and 1.25:l were selected for the Standard samplest, B and C respectively. Let the ampunts of cortisoi in the Standard mixtures be , 2 and Xa and the isotope ratios, äs measured by isotope dilution-mass spectrometry be RI, R2 and R3. From Eq. 9 and Eq. 10:
foS is calculated from Eq. 11 and inserted into Eq. 10, in order to obtain the parameter f 2 . After f 2 and foS have been calculated they are inserted into Eq. 3:
Ri + f 0 S (Eq. 12)
It should be noted that the term foS mainly reflects the amount of labelled cortisol S; the proportional factor f 0 depends on the isotope distribution in the labelled and the non-labelled substance and usually has a value which is close to one. Since it is difficult to measure the isotope distribution pattern in the labelled compouhd with high accuracy and precision, äs necessary for the definitive methodology* it is of great advantage to calculate the term foS from Standard mixtures äs described above. The BASIC Computer Programme by which the parameters of the theoretical curve and the results of the analyses are calculated is given in the Appendix.
Accuracy
The accuracy of tlie method described here for the determination of cortisol is based on the high specificity of mass spectrometry and on Hie oxäct control of fecovery employirig the principle of isotope dilution.
Precision
The cöefficients qf Variation from day to day äs determined in five different plasma pools are summarized in table 1. With one exception the cöefficients of Variation for a given concentration of cortisol in plasma are lower when calculated from meäsurements at m/z-values 605/ 607, äs compared to those calculated from measurements at m/z-values 636/638. This is due to the fivefold higher intensity of the M-31 fragment ion recorded at m/z 605.
The imprecision of the analytical results which is less than 2.4% is a result of several non-systematic errors in the measurement and calibration procedure. The coefficient of Variation for pipetting the serum samples in the ränge from 0.4 to 2.0 ml is about 0.12%; the imprecision of sampling the labelled intemal Standard solution with the 25 syringe was found to be 0.48% (C. V.); the coefficient of Variation for pipetting the diluted cortisol Standard solution with the 100 syringe was measured to 0.46% (C.V.). The imprecision of the mass spectrometer for the isotope ratio measurement at the m/z values 605 and 607 was calculated from duplicate measurements of the same samples. The coefficient of Variation varied from day to day depending on the performance of the Instrument and was in the ränge from 0.5 to 1.5%.
Tab. 1. Parameters of precision of the isotope dilution-mass spectrometry method for the determination of cortisol in human plasma. 
Sensitivity
The lower limit of detection, defined äs a 3:l ratio of Signal to noise, is 200 pg per sample, when measured at m/z value 605.
Discussion
The development of a definitive method requires the availability of a primary reference material of the analyte of high and accurately known purity. The cortisol preparation obtained äs certified reference material from the National Bureau of Standards is, according to the certificate, a well characterized substance of known purity which fulfils all criteria of a primary Standard and therefore is used äs Standard material in the present investigation.
With respect to the selection of a suitable isotope label for the internal Standard the possibility cannot be excluded that the isotope may undergo exchange in steroids, tritiated or deuterated in the ring skeleton. Therefore 14 C-labelled cortisol was selected in the present study äs internal Standard material since carbon atoms of the steroid molecule are very stable and not exchanged during the analytical procedure. However, 14 C-labelled cortisol may be replaced in future by cortisol which is labelled either with carbon 13 in the ring skeleton or with deuterium in an angular methyl group. The methoxime trimethylsilyl ether of cortisol proved to be the only derivative suitable for gas liquid chromatography-mass spectrometry because of its thermal stabüity. This derivative was originally described byÄringer & Gustafsson (4) and applied to mass fragmentography by Björkhem et al. (5) and by our group (2) . The method for the formation of the cortisol derivative by the üse of a mixture containing bromotrimethylsilane and N-methyl-N-trimethylsilyl-trifluoroacetic amide, äs described in this paper, was found to be advantageous, since the reaction mixture can be applied directly to the gas liquid chröma-tograph-mass spectrometer when packed Dexsil 300 columns are used. For the injection into a glass capillary column the reaction mixture may be easily evaporated under nitrogen at 60 °C and transferred to the tip of a moving needle inlet System (6) with a few microlitef s of cyclohexane.
It should be pointed out that during methoxime formation syn-anti isomeres of steroid ketones are formed (7) . These isomeric derivatives of cortisol are partiälly separated when an OV-101 capillary colurnn of about 25 m length is used. Due to this incomplete Separation, the quantitative results after use of the long capillary column are of lower precision. No advantage with respect to specificity or accuracy was observed for the cortisol analysis when the long glass capillary column was used in a few preliminary experiments. Therefore the packed Dexsil 300 or a short capillary column are used, since with these columns the two syn-anti isomeres are eluted äs one single well-defined peak, äs shown in figure l.
In the mass spectra of the cortisol derivative äs well äs the corresponding 14 C-labelled compound the peaks of highest intensities (base peaks) were found at m/z 605 and 607; they were used for selected ion monitoring. Simultaneously, an additional pair of ions was recorded at the m/z-values of the molecular ions (636, 638) . Measurements of these m/z-values were performed to check the results obtained at m/z 605 and 607.
As already mentipned, the determination of cortisol by isotope dilution-mass spectrometry is highly specific. This Statement is supported by the agreement of the results obtained by measurements at m/z-values 605/607 and 636/638, respectively. It can be seen from the table that the Variation of the differences between the two measurements (C.V. in the last column of tab. 1) is relatively low äs compared to the meän Variation of each of the two measurements.
In the present method for the measurement of a definitive value, the plasma sample to be analysed should contain cortisol in an ämount which exceeds the lower limit of detection (200 pg per sample) by ä fäctor of at least two hundred. This means in präctice that between 0.4 and 2 ml of normal plasma is required to measure ä definitive value.
In order to optimize the precision of the isotope dilü-tipn measurement, it is neeessary to select isotope r atios for Standards and samples which are not töo low and not too higji. Therefore, the final measurement of the definitive values is carried öüt at an isotope ratio which is close to one; this ratio is obtained by adjüsting the volume of the plasma sample rather thän the ämount of internal Standard ( [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]cortisol) added.
Furthermore it seems to be important that the isotope ratios in the Standard samples are close to that of the plasma sample; thus the three Standard samples used for the calibration of the parämeters of the Standard ctirve are mixed from non-läbelled and labelled cortisol with ratios of about 0.75: l, l: l and l .25: l; these Standard mixtures are prepafed with higih precision by the use pf a syringe eqüipped with a repeäting adaptor.
It should be emphäsized that all Volumetrie measurements are based öii weighing procedures since pipettes and syringes are calibrated by weighing äppf Ppriate amounts of water. This method improves the accuracy of the determination since the systematic errors asspciated with tfie weighing procedure are much lower äs compared to Volumetrie measurements, The calculatioii procedure, äs described in the present paper, is developed on well-founded theoretical futidamentals and therefore may be superiör to öther methods pf reading the analytical results from an empiric calibration curve or of calcülations by regression analysis. Calculation of the theoretical curve from three Standard mixtures makes it unnecessary to measure the exact ämount, the purity or the isotope distribution pattern of the labelled internal Standard; by calculating räther thari weighing the ämount of labelled Standard the total calibration procedure is based on the well chaf acterized certified reference cortisol; thus, the present method avoids several sources of errpr incuired in other definitive measuTement techniques that use a weighing proced ure for the internal Standard (8) .
The hierärchy eoncept of methods in clinical chemistry äs summarized in the approved recommendation of the International' Föderation of Clinical Chemistry (l, 9) comprises definitive methods, refef ence methods and methods pf known or unknown bias for rputine use.
Following this concept (9) the accuracy of methods which are in routine use in clinical chemical laboratories , should be confirmed by comparison with reference methods. The accuracy of reference methods must be established by comparison with definitive methods which reside at the highest level of the hierarchy scheme. The definitive values represent "the best known approximation to the true value".
On theoretical reasons there exists no final proof that a clinical chemical method, not even a definitive method, yields the "true" concentration value of an analyte in the biological matrix of a human body fluid. Therefore, the definition for definitive methods (1) includes the restriction that "no known source of inaccuracy" should be found; this implicates that the definition refers to the current state of art. In regard to this, the technique of isotope dilution-mass spectrometry, at present, provides the most suitable procedure for the development of a definitive method for the measurement of cortisol in human plasma.
Furthermore, it should be noted that exhaustive investigations are carried out in the present procedure in order to achieve optimal calibration and to confirm the accuracy of the results of the cortisol measurements. Therefore, the analytical procedure described here may be regarded s a definitive method.
On the basis of definitive values obtained by isotope dilution-mass spectrometry it will be possible to develop reference methods, e.g. by using high performance liquid chromatography, for the measurement of cortisol and finally to transfer accuracy to the level of routine methods. This will improve the reliability of radioimmunoassay and protein binding techniques which are currently in use for the measurement of cortisol in human plasma.
Despite the well proven accuracy of the isotope dilutionmass spectrometry procedure s described here, there still remain some small sources of uncertainty of the analytical results. In addition to the contribution of imprecision which is below 2.4% for the plasma samples tested, there m y be a small undetected bias due to systematic errors associated with the weighing procedure. This concerns the preparation of the cortisol stock solution s well s the calibration of the enzyme test pipettes used for measuring the plasma volume. This undetected error which is mainly due to the inaccuracy of the balances and of the officially calibrated test weights is assumed to be less than 0.5%. A further source of undetectable error is the possible inaccuracy of the cortisol content in the certified reference material (98.9%) which is estimated to be less than 0.2% s stated in the certificate of the National Bureau of Standards.
The present method has been used during the last four years for the determination of definitive values for cortisol in plasma pools for accuracy control in collaborative surveys.
